
|Videos|January 30, 2012
Preventing Pneumococcal Disease
Advertisement
Populations at risk for developing pneumococcal disease, including seniors, can benefit from the preventive protection of vaccination. Many adults who are older than 65 years did not receive any vaccination against pneumococcal disease as a child. In addition, adults with comorbid conditions are at additional risk for developing pneumococcal infection, and should educate themselves on the benefits of vaccination for preventing potentially life-threatening illness.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Blenrep Receives FDA Approval for Treatment of Relapsed or Refractory Multiple Myeloma
2
Two Doses of PCV20 in Lymphoma Survivors Elicits Greater Humoral Response
3
Elinzanetant Demonstrates Rapid and Sustained Efficacy in Reducing Vasomotor Symptoms Across OASIS Clinical Trials
4
Early Real-World Experience with VIMKUNYA Consistent with Clinical Trial Findings
5














































































































































































































